BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 1506799)

  • 1. Upper urinary tract transitional cell carcinoma in patients with bladder carcinoma.
    Pripatnanont C; Sujujantararat P
    J Med Assoc Thai; 1992 Mar; 75(3):190-4. PubMed ID: 1506799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Transitional cell carcinoma of the upper urinary tract following total cystectomy for bladder cancer].
    Hayashi Y; Tawada T; Ando Y
    Hinyokika Kiyo; 1992 Sep; 38(9):1015-8; discussion 1018-9. PubMed ID: 1414752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upper urinary tract recurrence after radical cystectomy for bladder cancer--who is at risk?
    Volkmer BG; Schnoeller T; Kuefer R; Gust K; Finter F; Hautmann RE
    J Urol; 2009 Dec; 182(6):2632-7. PubMed ID: 19836794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for subsequent development of bladder cancer after primary transitional cell carcinoma of the upper urinary tract.
    Matsui Y; Utsunomiya N; Ichioka K; Ueda N; Yoshimura K; Terai A; Arai Y
    Urology; 2005 Feb; 65(2):279-83. PubMed ID: 15708038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Superficial transitional cell carcinoma of the ureteral orifice: higher risk of developing subsequent upper urinary tract tumors.
    Chou EC; Lin AT; Chen KK; Chang LS
    Int J Urol; 2006 Jun; 13(6):682-5. PubMed ID: 16834642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of bilateral upper urinary tract tumors after radical cystectomy].
    Matsuda J; Kamizuru M; Bessho H; Terada T; Kim M
    Hinyokika Kiyo; 1997 Jul; 43(7):501-3. PubMed ID: 9282297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant methotrexate, vinblastine, adriamycin, and cisplatin chemotherapy has potential to prevent recurrence of bladder tumors after surgical removal of upper urinary tract transitional cell carcinoma.
    Soga N; Arima K; Sugimura Y
    Int J Urol; 2008 Sep; 15(9):800-3. PubMed ID: 18651862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upper tract urothelial recurrence following radical cystectomy for transitional cell carcinoma of the bladder: an analysis of 1,069 patients with 10-year followup.
    Sanderson KM; Cai J; Miranda G; Skinner DG; Stein JP
    J Urol; 2007 Jun; 177(6):2088-94. PubMed ID: 17509294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Four cases of upper urinary tract transitional cell carcinoma after radical cystectomy in bladder cancer].
    Nishio Y; Kaku S; Hida S; Ohishi K; Okada Y; Yoshida O
    Hinyokika Kiyo; 1988 Sep; 34(9):1593-9. PubMed ID: 3213794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endoscopic management of upper tract urothelial carcinoma in patients with a history of bladder urothelial carcinoma.
    Krambeck AE; Thompson RH; Lohse CM; Patterson DE; Segura JW; Zincke H; Elliott DS; Blute ML
    J Urol; 2007 May; 177(5):1721-6. PubMed ID: 17437796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The outcome of patients on dialysis with upper urinary tract transitional cell carcinoma.
    Wu CF; Chang PL; Chen CS; Chuang CK; Weng HH; Pang ST
    J Urol; 2006 Aug; 176(2):477-81. PubMed ID: 16813872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathologic features of bladder tumors after nephroureterectomy or segmental ureterectomy for upper urinary tract transitional cell carcinoma.
    Raman JD; Sosa RE; Vaughan ED; Scherr DS
    Urology; 2007 Feb; 69(2):251-4. PubMed ID: 17320658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of upper tract urothelial cell carcinoma after primary bladder cancer: a population based analysis.
    Wright JL; Hotaling J; Porter MP
    J Urol; 2009 Mar; 181(3):1035-9; discussion 1039. PubMed ID: 19150569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for intravesical recurrence after surgical management of transitional cell carcinoma of the upper urinary tract.
    Terakawa T; Miyake H; Muramaki M; Takenaka A; Hara I; Fujisawa M
    Urology; 2008 Jan; 71(1):123-7. PubMed ID: 18242379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upper tract tumour after radical cystectomy for transitional cell carcinoma of the bladder: incidence and risk factors.
    Sved PD; Gomez P; Nieder AM; Manoharan M; Kim SS; Soloway MS
    BJU Int; 2004 Oct; 94(6):785-9. PubMed ID: 15476508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Upper urothelium tumor in patients treated with radical cystectomy for transitional carcinoma of the bladder].
    Herranz Amo F; Verdú Tartajo F; Díez Cordero JM; Bueno Chomón G; Leal Hernández F; Bielsa Carrillo A
    Actas Urol Esp; 1999 Mar; 23(3):214-8. PubMed ID: 10363377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Synchronous tumor of the upper urinary tract with bladder cancer. Opportunity for nephroureterectomy and block-cystectomy].
    Navas Pastor J; García Ligero J; García García F; Tomás Ros M; Rico Galiano JL; Sempere Gutiérrez A; Gil Franco J; Fontana Compiano LO
    Arch Esp Urol; 2001 Dec; 54(10):1095-102. PubMed ID: 11852517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The risk of upper tract recurrence following cystectomy in patients with transitional cell carcinoma involving the distal ureter.
    Kenworthy P; Tanguay S; Dinney CP
    J Urol; 1996 Feb; 155(2):501-3. PubMed ID: 8558645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal risk of upper tract recurrence following radical cystectomy for urothelial cancer and the potential implications for long-term surveillance.
    Tran W; Serio AM; Raj GV; Dalbagni G; Vickers AJ; Bochner BH; Herr H; Donat SM
    J Urol; 2008 Jan; 179(1):96-100. PubMed ID: 17997449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imperative indications for conservative management of upper tract transitional cell carcinoma.
    Krambeck AE; Thompson RH; Lohse CM; Patterson DE; Elliott DS; Blute ML
    J Urol; 2007 Sep; 178(3 Pt 1):792-6; discussion 796-7. PubMed ID: 17632132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.